Entry Detail



General Information

Database ID:exR0083308
RNA Name:TMSB4X
RNA Type:mRNA
Chromosome:chrX
Starnd:+
Coordinate:
Start Site(bp):12975110End Site(bp):12977227
External Links:ENSG00000205542



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ACTB
chr7
5527148
5563784
-
ACTR2
chr2
65227753
65271253
+
AC006064.6
chr12
6556886
6607367
-
ADH5
chr4
99070978
99088801
-
ADPRH
chr3
119579268
119589945
+
ADGRL1
chr19
14147743
14206187
-
AGO2
chr8
140520156
140635633
-
AKT1
chr14
104769349
104795751
-
AC012184.2
chr16
70299194
70372582
+
AC093525.1
chr16
2513965
2527955
+
ADRM1
chr20
62302093
62308862
+
ALDOA
chr16
30064164
30070457
+
AC023055.1
chr12
55757275
55827546
-
AC139530.2
chr17
81703371
81720539
+
AL162417.1
chr9
133098121
133163914
-
AC048338.1
chr12
122207779
122266423
-
AL021546.1
chr12
120438198
120460006
+
AC073508.2
chr17
40627356
40665141
-
ABT1
chr6
26596953
26600739
+
AC073896.1
chr12
56285916
56316059
-
ABHD5
chr3
43690108
43734371
+
AGPAT5
chr8
6708642
6761503
+
ADSL
chr22
40346500
40390463
+
ADORA2A
chr22
24417879
24442357
+
ACAP1
chr17
7336529
7351477
+
AKAP13
chr15
85380571
85749358
+
ACTR1A
chr10
102461881
102502712
-
AFTPH
chr2
64524305
64593005
+
ADD2
chr2
70607618
70768225
-
ACOT7
chr1
6264269
6394391
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-142-3p
chr17
58331245
58331267
-
hsa-miR-155-5p
chr21
25573983
25574006
+
hsa-miR-4442
chr3
25664875
25664891
-
hsa-miR-7847-3p
chr11
1880105
1880125
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004554.2
chrX
11668401
11757718
-
AC004687.1
chr17
58330884
58332508
-
AC005618.1
chr5
141326210
141329357
+
AC005899.4
chr17
32328441
32329395
+
AC007744.1
chr2
56147630
56386171
+
AC007780.1
chr17
68413623
68524949
+
AC007952.4
chr17
19112000
19112636
-
AC010247.1
chr19
42132555
42137099
+
AC017104.1
chr2
231388976
231394991
+
AC022167.2
chr16
8848105
8860456
+
AC024940.6
chr12
31280422
31280895
-
AC026362.1
chr12
122975320
122982907
+
AC026461.1
chr16
56682470
56687807
+
AC026471.1
chr16
31456711
31459736
-
AC055854.1
chr8
22690150
22798616
+
AC063949.2
chr12
92421531
92483680
+
AC073896.4
chr12
56162359
56190284
-
AC114271.1
chr19
10333436
10336248
+
AC139149.1
chr17
81514047
81527776
+
AC245014.3
chr1
145281116
145281462
+
AD000090.1
chr19
35557956
35581954
+
AJ271736.1
chrX
156004218
156022236
+
AL022311.1
chr22
37876148
37895563
+
AL035458.2
chr20
34234840
34281173
-
AL096870.2
chr14
24209646
24215987
-
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA